Sandoz Canada Makes Its Mark In Oncology Biosimilars
Two Launches Delivered Following Approvals
Sandoz Canada is continuing to expand its biosimilars footprint with entry into oncology, while also broadening its presence for autoimmune disorders like rheumatoid arthritis.
